In newborns, a bilirubin level of 20 mg/dL or higher is generally considered high and typically requires treatment. Levels at or above 25 mg/dL raise concern for potential brain damage, and levels above 30 mg/dL are classified as hazardous hyperbilirubinemia. The exact threshold that’s dangerous for any individual baby depends on their age in hours, gestational age, and whether they have additional risk factors.
Normal Bilirubin Levels in the First Week
Almost all newborns develop some degree of jaundice. Bilirubin, the yellow pigment that causes the skin to look yellow, builds up because a newborn’s liver isn’t yet efficient at processing it. This normal, or “physiologic,” jaundice typically becomes visible around day two of life, peaks between days three and five, and resolves within two weeks. During this window, bilirubin levels commonly reach 5 to 12 mg/dL in healthy, full-term babies without causing any concern.
Because bilirubin peaks in those first few days, the 2022 American Academy of Pediatrics guideline recommends that every newborn have their bilirubin measured at least once before leaving the hospital. That measurement helps determine when follow-up testing is needed after discharge.
Where the Thresholds Start to Matter
There isn’t a single number that separates “safe” from “dangerous” for every baby. Instead, doctors use hour-specific charts that plot the baby’s bilirubin level against their exact age in hours. A level of 15 mg/dL at 48 hours old means something different than 15 mg/dL at 96 hours old. Phototherapy (light therapy) thresholds also shift based on gestational age and the presence of neurotoxicity risk factors like prematurity, significant bruising, or blood-type incompatibility between mother and baby.
That said, some general landmarks help put the numbers in context:
- Above 15 mg/dL: Often triggers closer monitoring or phototherapy, depending on the baby’s age and risk profile.
- Above 20 mg/dL: Considered severe hyperbilirubinemia. Phototherapy is almost always indicated, and bilirubin rising faster than 6 mg/dL per day is a red flag regardless of the absolute number.
- Above 25 mg/dL: The risk of bilirubin-related brain injury begins to climb, particularly when additional risk factors are present. In babies with risk factors like Rh incompatibility, 90% of brain injury cases in one large study were identified at or above 25.4 mg/dL.
- Above 30 mg/dL: Classified as hazardous. At these levels, even otherwise healthy babies without risk factors can develop complications.
Risk Factors That Lower the Danger Threshold
A baby born at 37 weeks without complications can tolerate higher bilirubin levels than a baby born at 35 weeks with a blood-type mismatch. Risk factors that make a baby more vulnerable to bilirubin’s effects include being born before 38 weeks, having a blood-type incompatibility (particularly Rh disease), glucose-6-phosphate dehydrogenase deficiency (a common inherited enzyme condition), and significant birth-related bruising or bleeding.
The difference these risk factors make is substantial. In a study of newborns with severe jaundice, brain injury first appeared at bilirubin levels above 31.5 mg/dL in babies without risk factors. But in babies with Rh incompatibility, the threshold dropped to about 25 mg/dL. ABO blood-type incompatibility fell in between, with a threshold around 33.7 mg/dL. This is why doctors don’t rely on a single cutoff number. The same bilirubin level can be reassuring in one baby and alarming in another.
Why Bilirubin Can Damage the Brain
At very high concentrations, bilirubin crosses into the brain and damages nerve cells. The acute form, called acute bilirubin encephalopathy, causes symptoms like extreme sleepiness, poor feeding, a high-pitched cry, and abnormal muscle tone. If caught early and treated aggressively, this can be reversed. If it progresses, it can cause permanent brain damage known as kernicterus, which involves hearing loss, movement disorders, and intellectual disability.
In healthy term babies without risk factors, bilirubin levels between 25 and 30 mg/dL carry relatively little risk of encephalopathy. No cases of acute brain injury were observed below 31.8 mg/dL in one study of babies without additional vulnerabilities. But this doesn’t mean those levels are safe to ignore. Treatment at lower thresholds exists precisely to prevent bilirubin from climbing into truly dangerous territory.
How Jaundice Is Treated
Phototherapy is the standard first-line treatment. Your baby lies under special blue-spectrum lights (sometimes on a light-emitting blanket) that break down bilirubin in the skin so it can be excreted without the liver needing to process it. Most babies need phototherapy for one to two days. The treatment is painless, though your baby will wear eye shields and may be fussier than usual from being undressed under the lights.
If bilirubin levels are extremely high or rising rapidly despite phototherapy, an exchange transfusion may be needed. This procedure gradually replaces the baby’s blood with donor blood to quickly lower bilirubin concentration. It’s rare and reserved for the most severe cases.
Breastfeeding and Jaundice
Two distinct types of jaundice are linked to breastfeeding, and they behave differently. The first, sometimes called breastfeeding failure jaundice, happens in the first few days of life when a baby isn’t getting enough milk. Without adequate feeding, the baby has fewer bowel movements and clears bilirubin more slowly. Feeding more frequently, every two to three hours, is the primary solution.
The second type, breast milk jaundice, appears after the first week and is caused by substances in breast milk that slow bilirubin breakdown. It can keep bilirubin mildly elevated for several weeks but rarely reaches levels that need treatment. In most cases, continuing to breastfeed is recommended.
What Jaundice Looks Like on Your Baby
Jaundice follows a predictable pattern on the body. It starts on the face and head, then spreads downward to the chest, abdomen, arms, and finally the legs and feet. The further down the body the yellow color extends, the higher the bilirubin level is likely to be. Yellowing limited to the face suggests a lower level, while yellow palms and soles suggest levels that need immediate evaluation.
Visual assessment has limits, especially in babies with darker skin tones. Pressing gently on the forehead or nose and looking at the underlying skin color can help, but it’s not a reliable substitute for a blood or skin-sensor measurement. If your baby looks increasingly yellow, is feeding poorly, seems unusually sleepy or difficult to wake, or has a high-pitched cry, those are signs that bilirubin may be climbing to a level that needs prompt treatment.